Publications To Date

    NANOSTRING PUBLICATIONS

    Filter Publications

    PAGE 63 OF 87 | DISPLAYING 931 - 945 OF 1293 RESULTS

    Polley E. et al., Small Cell Lung Cancer Screen of Oncology Drugs, Investigational Agents, and Gene and microRNA Expression., [Epub ahead of print]., JNCI, May 22, 2016

    Quail D.F. et al., The tumor microenvironment underlies acquired resistance to CSF-1R inhibition in gliomas., [Epub ahead of print]., Science, May 20, 2016

    Gurard-Levin Z.A. et al., Chromatin regulators as a guide for cancer treatment choice, [Epub ahead of print]., Mol. Can. Ther., May 18, 2016

    Gyanchandani R. et al., Intra-tumor heterogeneity affects gene expression profile test prognostic risk stratification in early breast cancer., [Epub ahead of print]., Clin. Can. Res., May 16, 2016

    Guo X. et al., Long-term soy consumption and tumor tissue MicroRNA and gene expression in triple-negative breast cancer., [Epub ahead of print]., Cancer, May 16, 2016

    Klintman M. et al., Changes in Expression of Genes Representing Key Biologic Processes after Neoadjuvant Chemotherapy in Breast Cancer, and Prognostic Implications in Residual Disease., [Epub ahead of print]., Clin. Can. Res., May 15, 2016

    Pearson A. et al., High-Level Clonal FGFR Amplification and Response to FGFR Inhibition in a Translational Clinical Trial., [Epub ahead of print]., Cancer Discovery, May 13, 2016

    Spoerke J.M. et al., Heterogeneity and clinical significance of ESR1 mutations in ER-positive metastatic breast cancer patients receiving fulvestrant., [Epub ahead of print]., Nat. Commun., May 13, 2016

    Chen X. et al., Comparison of Nanostring nCounter Data on FFPE Colon Cancer Samples and Affymetrix Microarray Data on Matched Frozen Tissues, [Epub ahead of print]., PLoS ONE, May 11, 2016

    Georgescu I. et al., Molecular characterization of Gleason patterns 3 and 4 prostate cancer using reverse Warburg effect-associated genes, [Epub ahead of print]., Cancer Met., May 05, 2016

    Savage K.J. et al., Impact of dual expression of MYC and BCL2 by immunohistochemistry on the risk of CNS relapse in DLBCL, [Epub ahead of print]., Blood, May 05, 2016

    Rajamani D. et al., Identification of key regulators of pancreatic cancer progression through multidimensional systems-level analysis, , Genome Med., May 03, 2016

    Chen Z. et al., cAMP/CREB-regulated LINC00473 marks LKB1-inactivated lung cancer and mediates tumor growth., [Epub ahead of print]., JCI, May 03, 2016

    Muro K. et al., Pembrolizumab for patients with PD-L1-positive advanced gastric cancer (KEYNOTE-012): a multicentre, open-label, phase 1b trial, [Epub ahead of print]., The Lancet Oncology, May 03, 2016

    Yang S. et al., A novel MIF signaling pathway drives the malignant character of pancreatic cancer by targeting NR3C2, [Epub ahead of print]., Cancer Res., Apr 20, 2016